Invention Grant
US09540379B2 (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
有权
（1,2,4）三唑并[4,3-A]喹喔啉衍生物作为磷酸二酯酶的抑制剂
![(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases](/docs/US/2017-01-10/US09540379B2/abs.jpg.600x600.jpg)
- Patent Title: (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
- Patent Title (中): （1,2,4）三唑并[4,3-A]喹喔啉衍生物作为磷酸二酯酶的抑制剂
-
Application No.: US13361002Application Date: 2012-01-30
-
Publication No.: US09540379B2Publication Date: 2017-01-10
- Inventor: Hans-Joachim Lankau , Barbara Langen , Christian Grunwald , Norbert Hoefgen , Hans Stange , Rita Dost , Ure Egerland
- Applicant: Hans-Joachim Lankau , Barbara Langen , Christian Grunwald , Norbert Hoefgen , Hans Stange , Rita Dost , Ure Egerland
- Applicant Address: DE Ingelheim
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D487/04 ; A61K31/519 ; A61K45/06
![(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases](/abs-image/US/2017/01/10/US09540379B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to (1,2,4)triazolo[4,3-a]quinoxaline derivatives which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases.
Public/Granted literature
- US20120302564A1 (1,2,4)TRIAZOLO[4,3-A]QUINOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES Public/Granted day:2012-11-29
Information query
